After Phase 3 readout, Ionis set on launching FCS agent this year
Having shared full Phase 3 data for rare-disease agent olezarsen earlier this week, execs have their sights set on a 2024 filing and launch.
Source: mmm-online.com
Stay updated with breaking news from Kyle Jenne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Having shared full Phase 3 data for rare-disease agent olezarsen earlier this week, execs have their sights set on a 2024 filing and launch.